13th edition

Format
HYBRID

December 3rd & 4th, 2024

IN-PERSON | LILLE, FR

December 11th& 12th 2024

ONLINE MEETINGS

Valentine Delabie

Roche, bronze sponsor of BioFIT 2023

Roche, bronze sponsor of BioFIT 2023

We are very pleased to count, this year again, Roche among our sponsors

Many thanks for your major interest in BioFIT, since 2016

Roche is the world’s largest biotech company and #1 investor into R&D, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the CNS. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare. Our Pharma Partnering team provides comprehensive BD and alliance management support for Roche and Genentech’s R&D units and the broader pharmaceutical division. Alongside the broad internal pipeline, external innovation has always been a critical component of our R&D strategy.

Join key BioFIT 2023 sponsors such as Genfit, Pfizer, CAPTECH Santé Nutrition, Zoetis, Roche and Boehringer Ingelheim to have the opportunity to:

  • Identify your organisation with the main partnering event in Europe dedicated to tech transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
  • Highlight your interest in early-stage innovation
  • Present your ideas and technologies to key innovation players in Life Sciences
  • Enhance your visibility on an international scale and be recognised as a key innovative actor
  • Show your expertise thanks to specific communication tools

For more information about the sponsorship opportunities, visit the dedicated site page.

Sponsors

Contact

Vincent Tavernier

Roche, bronze sponsor of BioFIT 2023 Read More »

Do not miss the Early Bird offer!

Do not miss the Early Bird offer!

The full pass gives access to all BioFIT activities:

🤝One-on-one meetings: BioFIT’s partnering platform is the most efficient way to identify and connect with potential business, research and financial partners. The partnering activity enables BioFIT’s participants to meet each other during 30-minute pre-qualified one-on-one meetings organised prior to the event.

🎤Conference and roundtable discussions: Steered by a prestigious Committee, the BioFIT conference programme brings together bright minds to discuss the latest trends in the Life Sciences field.

🚀Pitch sessions: BioFIT pitch sessions identify the most innovative and promising start-ups, companies, R&D projects and licensing opportunities in the Life Sciences and Animal Health sectors.

💬Exhibition: The exhibition area enables participants to access key information, expand their network, highlight their skills, services and innovations, boost their visibility and generate informal meetings.

👨🏼‍🤝‍👨🏻Project – CEO matchmaking: As talented CEOs are frequently sought-after by many players in the Life Sciences industry, the Project – CEO matchmaking activity aims to connect representatives of emerging start-ups, technology transfer offices, incubators and investing networks with CEOs and aspiring CEOs.

Ideally located at the focal point of the event, the exhibition area gives you the opportunity to:

📢 Enhance your visibility among innovative leaders in the sector gathering at BioFIT
📈 Maximise your business opportunities, expand your network and showcase your assets
🌟 Highlight your company thanks to descriptions on our communication tools
 

Secure your spot: first-come, first-served!

Sponsors

Contact

Vincent Tavernier

Do not miss the Early Bird offer! Read More »

Zoetis supports BioFIT this year again

Zoetis supports BioFIT this year again

We are greatful to count Zoetis among our BioFIT 2023 sponsors

As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After 70 years innovating ways to predict, prevent, detect, and treat animal illness, we continue to stand by those raising and caring for animals worldwide – from livestock farmers to veterinarians and pet owners. A Fortune 500 company, we generated revenue of $7.8 billion in 2021 with ~12,100 employees. For more, visit www.zoetis.com.

Join key BioFIT 2023 sponsors such as Genfit, Pfizer, CAPTECH Santé Nutrition, Zoetis and Boehringer Ingelheim to have the opportunity to:

  • Identify your organisation with the main partnering event in Europe dedicated to tech transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
  • Highlight your interest in early-stage innovation
  • Present your ideas and technologies to key innovation players in Life Sciences
  • Enhance your visibility on an international scale and be recognised as a key innovative actor
  • Show your expertise thanks to specific communication tools

For more information about the sponsorship opportunities, visit the dedicated site page.

Sponsors

Contact

Vincent Tavernier

Zoetis supports BioFIT this year again Read More »

CAPTECH Santé Nutrition, new sponsor of BioFIT 2023

CAPTECH Santé Nutrition, new sponsor of BioFIT 2023

BioFIT event is delighted to welcome CAPTECH Santé Nutrition
as a Contributing sponsor

Captech Santé Nutrition is the first French sectoral and regional fund. Its ambition: to meet the challenges of innovation in health and nutrition in Hauts-de-France.

Join key BioFIT 2023 sponsors such as Genfit, Pfizer, CAPTECH Santé Nutrition and Boehringer Ingelheim to have the opportunity to:

  • Identify your organisation with the main partnering event in Europe dedicated to tech transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
  • Highlight your interest in early-stage innovation
  • Present your ideas and technologies to key innovation players in Life Sciences
  • Enhance your visibility on an international scale and be recognised as a key innovative actor
  • Show your expertise thanks to specific communication tools

For more information about the sponsorship opportunities, visit the dedicated site page.

Sponsors

Contact

Vincent Tavernier

CAPTECH Santé Nutrition, new sponsor of BioFIT 2023 Read More »

Present your innovation at BioFIT

Present your innovation at BioFIT

Are you looking for funding, partnerships, and development opportunities in Life Sciences? 

The BioFIT pitch competition allows you to showcase your innovation in front of a high-quality audience composed of renowned corporates, investors and other potential partners.
Ready to bring your project to the next level? Apply for the pitch sessions!

To which session should I apply?

🚀 I am a start-up, and I am actively looking to raise funds

 👉 The Start-up Slams are perfect to promote your innovation in front of Life Sciences investors and corporates

Merck’s Advance Biotech Grant Award
    

Merck is awarding a special prize to the best start-up working on a biopharmaceutical therapeutic during the Start-up Slams 🏆

Merck is a vibrant science and technology company energised by a passionate curiosity about the world around us. We solve problems at every stage of the pharmaceutical value chain, from discovery and development to processing, manufacturing and diagnostics.

To show our dedication to supporting start-ups, we offer Start-up Slams participants working on biopharmaceutical therapeutics, the opportunity to win an additional specific Merck prize – The Merck Advance Biotech Grant Award. This prize includes €30,000 to be used towards Merck’s Bioprocessing technologies, Process Development Consultation & Services, plus 2 hours of consultation time with M ventures.

🔎 I am a TTO, university, research institute or company with a collaboration and/or out-licensing opportunity.
I am a mature company looking to out-license an innovative asset.

👌 The Collaborative and Licensing Opportunity Presentations are perfect to find your future partners

🐾 I have an innovative project in relation to animal well-being and health

👍 The Animal Health Presentations are a great opportunity to showcase your project to animal health experts and potential partners and investors

Co-organised by:     within    

Sponsors

Contact

Vincent Tavernier

Present your innovation at BioFIT Read More »

You are a bioentrepreneur seeking new challenges or you are looking for a passionate CEO to lead your project?

You are a bioentrepreneur seeking new challenges or you are looking for a passionate CEO to lead your project?

If so, the Project – CEO matchmaking is made for you!

As talented CEOs are frequently sought-after by many players in the biotech industry, the Project – CEO matchmaking activity aims to connect representatives of emerging start-ups, technology transfer offices, incubators, and investing networks with CEOs and aspiring CEOs.

 Find the perfect match:
• Any incubatortechnology transfer entity or scientific founder looking for an entrepreneur to lead their innovative projects is welcome to participate in the matchmaking activity to meet with qualified candidates!
 You will be visible on the partnering platform, to be contacted by potential CEOs.

• If you are a bioentrepreneur looking for a new project to undertake: 
→ Projects looking for a CEO will be visible on the platform and easily identifiable.

Get inspired: 
Having the right team is essential for the development of a biotech project. The Project – CEO matchmaking activity also offers a conference session to get inspired and explore the best ways to find the right talents for a successful project:

Biotech start-up governance:
What makes a good foundation for a company to deliver and grow?

Not registered yet?

Benefit from exclusive discounts with the Early Bird offer,
valid until July 20th, 2023  

Sponsors

Contact

Vincent Tavernier

You are a bioentrepreneur seeking new challenges or you are looking for a passionate CEO to lead your project? Read More »

Pfizer: Gold sponsor of BioFIT 2023

Pfizer: Gold sponsor of BioFIT 2023

We are glad to welcome Pfizer as a Gold sponsor of BioFIT 2023

Many thanks for your support since 2017!

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us.

Join key BioFIT 2023 sponsors such as  Genfit, Pfizer and Boehringer Ingelheim to have the opportunity to:

  • Identify your organisation with the main partnering event in Europe dedicated to tech transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
  • Highlight your interest in early-stage innovation
  • Present your ideas and technologies to key innovation players in Life Sciences
  • Enhance your visibility on an international scale and be recognised as a key innovative actor
  • Show your expertise thanks to specific communication tools

For more information about the sponsorship opportunities, visit the dedicated site page.

Sponsors

Contact

Juliette Vanbastelaere

Pfizer: Gold sponsor of BioFIT 2023 Read More »

Share your expertise at BioFIT 2023!

Share your expertise at BioFIT 2023!

Steered by its prestigious committee, the BioFIT conference programme is shaped to correspond to the interests of every player in the sector and to meet the expectations of its stakeholders, whose sharp minds operate in the fast-paced Life Sciences sector. The 2023 programme is rooted in four custom-made tracks, addressing the right funding sources for early-stage innovation, best practices in academia-industry R&D collaborations, winning ways to nurture early-stage assets and animal health highlights.

Look back at the 2022 conferences:

PLENARY SESSION
Biopharma industry has been facing uncertainties in 2023:
What is the impact for early-stage partnering and financing strategies?

The current economic and geopolitical contexts have been difficult for innovation around the world and life sciences are no exception. In a period of inflation, war, high energy prices and financial strains, investments have been shrinking. This session will explore the specific challenges facing the sector and strategies for making the most of the current reality to ensure that biotech innovation continues to be funded and thrive in a complex landscape.

What are the current key issues in the EU biotech ecosystem compared to the US, particularly with regard to drug pricing pressure? What has been the support of public and non-profit organisations to the sector? How has the reduced ability of funds to raise money impacted on the availability of capital in the short to medium term? To what extent does the decline in asset prices impact on the external innovation strategies of pharmaceutical companies? How does balancing the need for innovation with financial viability allow for broader sources of innovation and the structuring of new early-stage collaborations? What is the outlook for life sciences dealmaking in 2024?

 Track 1 – Best practices in R&D collaborations 

Fostering academia-industry partnerships is key to driving innovation in Life Sciences. Which sectors are prone to fuel collaborations? What are the elements to forgather to merge the scientific, academic, advocacy and industry spheres? How are the advances in specific fields influencing academia-pharma partnerships?
 

What are pharma companies’ expectations for pre-competitive research?
• • •
Evolution of collaborative practices in Biotech startups/Academia partnerships
• • •
Best practices for managing risk in early-stage
academia-industry collaborations

Track 2 – Nurturing and licensing early-stage assets

Early-stage assets evolve in an ecosystem where TTOs, scientists and entrepreneurs are closely connected. Understanding the mechanisms and difficulties in nurturing and licensing assets is key to properly influencing the valuation of these assets at an early stage. How can we transform science into business more frequently and efficiently?
 

Adding value to early-stage assets through partnering: What are the working models and how to valorise the partnerships?
• • •
From lab to start-up: Let’s hear about successful spin-out journey
• • •
How are tech transfer offices selecting the projects to back?

Track 3 – From pre-seed to Series A: 
 Accessing early-stage investment 

This track aims to understand the mechanisms enforcing investors’ presence in early stages of development. Are we witnessing surges of investment in specific therapeutic areas? Who are the new players involved in investing in the biotech sector and what are their pre-requisites?
 

From Seed to Series A: What will spark investors’ interest in 2024?
• • •
Exploring the pharma-VC relationship:
How do they build complementary investment strategies?

• • •
What’s new in grant financing across Europe and how to prepare for it?

 Track 4 – Animal Health Highlights 

This track features the latest innovation challenges in animal health R&D and intends to provide a clear understanding of the bridges that can be built between human and animal health. International experts from veterinary research and industry will discuss the latest initiatives to improve and accelerate the development of new diagnostics, vaccines and pharmaceuticals for animal diseases and beyond.
 

Sourcing innovations from a more mature human health market to build assets and start-ups in animal health: How is this happening?
• • •

 Project – CEO matchmaking 

Having the right team is essential for the development of a biotech project or start-up. The Project – CEO matchmaking activity also offers a conference session to get inspired and explore the best ways to find the right talent for a successful project.
 

Biotech start-up governance: What makes a good foundation for a company to deliver and grow?
• • •

Sponsors

Contact

Vincent Tavernier

Share your expertise at BioFIT 2023! Read More »

We are pleased to welcome Boehringer Ingelheim among our 2023 sponsors

We are pleased to welcome Boehringer Ingelheim among our 2023 sponsors

BioFIT event has the honor to count among its sponsors:
Boehringer Ingelheim

Many thanks for your support since 2016!

Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. More than 52,000 employees serve over 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.

Join key BioFIT 2023 sponsors such as  Genfit and Boehringer Ingelheim to have the opportunity to:

  • Identify your organisation with the main partnering event in Europe dedicated to tech transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
  • Highlight your interest in early-stage innovation
  • Present your ideas and technologies to key innovation players in Life Sciences
  • Enhance your visibility on an international scale and be recognised as a key innovative actor
  • Show your expertise thanks to specific communication tools

For more information about the sponsorship opportunities, visit the dedicated site page.

Sponsors

Contact

Juliette Vanbastelaere

We are pleased to welcome Boehringer Ingelheim among our 2023 sponsors Read More »

Join us for the next edition of BioFIT

Join us for the next edition of BioFIT

We hope to have the pleasure to welcome you to the 12th edition of BioFIT
in Marseille, on December 12th and 13th, 2023
and online on December 15th, 2023

With over 1,000 international delegates from 35+ countries (big pharma, emerging and small biotech, diagnostic companies, investors, tech transfer professionals, academia and research institutions), BioFIT is the leading partnering event in Europe for technology transferacademia-industry collaborations and early-stage innovation deals in the field of Life Sciences, as well as the European marketplace for pre-seed, seed and Series A investment rounds in the sector.

Different options to participate in BioFIT:

The partnering activity is the most efficient way to identify and connect with your future project partners, obtain funding and accelerate innovation. BioFIT partnering platform allows to pre-organise one-on-one meetings and optimise the time spent at the event.

Ideally located at the focal point of the event, the exhibition area enables participants to access key information, expand their network, highlight their skills, services and innovations and enhance their visibility.

The BioFIT pitch sessions offer the opportunity to detect the most innovative and promising start-ups, R&D projects and licensing opportunities in order to foster partnerships and business development in the Life Sciences and Animal Health fields.

Steered by a prestigious committee, the 2023 conference programme is rooted in four custom-made tracks, addressing the right funding sources for early-stage innovation, best practices in academia-industry R&D collaborations, winning ways to nurture early-stage assets and animal health highlights.

Register before April 13th, 2023 to
benefit from the Super Early Bird offer!

Sponsors

Contact

Vincent Tavernier

Join us for the next edition of BioFIT Read More »

Scroll to Top
  • No products in the cart.